Do analysts rate MGRX or BMGL?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Mangoceuticals 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Basel Medical Group 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable earnings and valuation, MGRX or BMGL?

Basel Medical Group has higher revenue and earnings than Mangoceuticals. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Mangoceuticals $460K 17.96 -$20.64M -$1.01 N/A Basel Medical Group $8.90M 0.85 -$9.50M N/A N/A

Do analysts prefer BMGL or AIDX?

20/20 Biolabs has a consensus price target of $5.00, indicating a potential upside of 702.57%. Given 20/20 Biolabs' stronger consensus rating and higher probable upside, analysts clearly believe 20/20 Biolabs is more favorable than Basel Medical Group. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Basel Medical Group 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 20/20 Biolabs 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has stronger earnings and valuation, BMGL or AIDX?

20/20 Biolabs has lower revenue, but higher earnings than Basel Medical Group. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Basel Medical Group $8.90M 0.85 -$9.50M N/A N/A 20/20 Biolabs $2.05M 3.88 -$3.74M -$0.54 N/A

Is BMGL or AIDX more profitable?

Company Net Margins Return on Equity Return on Assets Basel Medical Group N/A N/A N/A 20/20 Biolabs N/A N/A N/A

Does the media refer more to BMGL or AIDX?

In the previous week, Basel Medical Group and Basel Medical Group both had 1 articles in the media. Basel Medical Group's average media sentiment score of 1.14 beat 20/20 Biolabs' score of 0.00 indicating that Basel Medical Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Basel Medical Group 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive 20/20 Biolabs 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer BMGL or GXAI?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Basel Medical Group 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Gaxos.ai 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better earnings and valuation, BMGL or GXAI?

Gaxos.ai has lower revenue, but higher earnings than Basel Medical Group. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Basel Medical Group $8.90M 0.85 -$9.50M N/A N/A Gaxos.ai $1.93M 2.82 -$3.90M -$0.50 N/A

Do analysts prefer NIVF or BMGL?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NewGenIvf Group 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Basel Medical Group 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable valuation & earnings, NIVF or BMGL?

NewGenIvf Group has higher earnings, but lower revenue than Basel Medical Group. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio NewGenIvf Group $4.73M 0.48 $9.88M N/A N/A Basel Medical Group $8.90M 0.85 -$9.50M N/A N/A

Is NIVF or BMGL more profitable?

Company Net Margins Return on Equity Return on Assets NewGenIvf Group N/A N/A N/A Basel Medical Group N/A N/A N/A

Does the media favor NIVF or BMGL?

In the previous week, NewGenIvf Group had 6 more articles in the media than Basel Medical Group. MarketBeat recorded 7 mentions for NewGenIvf Group and 1 mentions for Basel Medical Group. NewGenIvf Group's average media sentiment score of 1.65 beat Basel Medical Group's score of 1.14 indicating that NewGenIvf Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment NewGenIvf Group 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Basel Medical Group 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer BMGL or IVF?

INVO Fertility has a consensus price target of $20.00, suggesting a potential upside of 1,920.20%. Given INVO Fertility's stronger consensus rating and higher possible upside, analysts clearly believe INVO Fertility is more favorable than Basel Medical Group. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Basel Medical Group 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 INVO Fertility 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.50

Which has preferable valuation & earnings, BMGL or IVF?

Basel Medical Group has higher revenue and earnings than INVO Fertility. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Basel Medical Group $8.90M 0.85 -$9.50M N/A N/A INVO Fertility $6.84M 0.36 -$25.13M -$33.83 N/A

Does the media prefer BMGL or IVF?

In the previous week, INVO Fertility had 1 more articles in the media than Basel Medical Group. MarketBeat recorded 2 mentions for INVO Fertility and 1 mentions for Basel Medical Group. Basel Medical Group's average media sentiment score of 1.14 beat INVO Fertility's score of 0.00 indicating that Basel Medical Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Basel Medical Group 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive INVO Fertility 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Basel Medical Group (BMGL) Competitors

$4.88 +0.10 (+1.99%)

As of 10:29 AM Eastern

Compare

BMGL vs. MGRX, AIDX, GXAI, NIVF, and IVF

Should you buy Basel Medical Group stock or one of its competitors? Basel Medical Group's main competitors and comparable companies include Mangoceuticals (MGRX), 20/20 Biolabs (AIDX), Gaxos.ai (GXAI), NewGenIvf Group (NIVF), and INVO Fertility (IVF). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does Basel Medical Group compare to Mangoceuticals?

Mangoceuticals (NASDAQ:MGRX) and Basel Medical Group (NASDAQ:BMGL) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, risk, dividends, earnings, institutional ownership, analyst recommendations, valuation and media sentiment.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mangoceuticals	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Basel Medical Group	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Basel Medical Group has a net margin of 0.00% compared to Mangoceuticals' net margin of -4,794.60%. Basel Medical Group's return on equity of 0.00% beat Mangoceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Mangoceuticals	-4,794.60%	-96.39%	-89.60%
Basel Medical Group	N/A	N/A	N/A

56.7% of Mangoceuticals shares are held by institutional investors. 16.0% of Mangoceuticals shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, Basel Medical Group had 1 more articles in the media than Mangoceuticals. MarketBeat recorded 1 mentions for Basel Medical Group and 0 mentions for Mangoceuticals. Basel Medical Group's average media sentiment score of 1.14 beat Mangoceuticals' score of 0.00 indicating that Basel Medical Group is being referred to more favorably in the news media.

Company	Overall Sentiment
Mangoceuticals	Neutral
Basel Medical Group	Positive

Mangoceuticals has a beta of 2.04, meaning that its share price is 104% more volatile than the broader market. Comparatively, Basel Medical Group has a beta of 0.26, meaning that its share price is 74% less volatile than the broader market.

Basel Medical Group has higher revenue and earnings than Mangoceuticals.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mangoceuticals	$460K	17.96	-$20.64M	-$1.01	N/A
Basel Medical Group	$8.90M	0.85	-$9.50M	N/A	N/A

Summary

Basel Medical Group beats Mangoceuticals on 7 of the 11 factors compared between the two stocks.

How does Basel Medical Group compare to 20/20 Biolabs?

Basel Medical Group (NASDAQ:BMGL) and 20/20 Biolabs (NASDAQ:AIDX) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, media sentiment, dividends, valuation, risk, profitability and institutional ownership.

20/20 Biolabs has a consensus price target of $5.00, indicating a potential upside of 702.57%. Given 20/20 Biolabs' stronger consensus rating and higher probable upside, analysts clearly believe 20/20 Biolabs is more favorable than Basel Medical Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Basel Medical Group	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
20/20 Biolabs	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Company	Net Margins	Return on Equity	Return on Assets
Basel Medical Group	N/A	N/A	N/A
20/20 Biolabs	N/A	N/A	N/A

In the previous week, Basel Medical Group and Basel Medical Group both had 1 articles in the media. Basel Medical Group's average media sentiment score of 1.14 beat 20/20 Biolabs' score of 0.00 indicating that Basel Medical Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Basel Medical Group	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
20/20 Biolabs	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

20/20 Biolabs has lower revenue, but higher earnings than Basel Medical Group.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Basel Medical Group	$8.90M	0.85	-$9.50M	N/A	N/A
20/20 Biolabs	$2.05M	3.88	-$3.74M	-$0.54	N/A

Summary

20/20 Biolabs beats Basel Medical Group on 5 of the 7 factors compared between the two stocks.

How does Basel Medical Group compare to Gaxos.ai?

Basel Medical Group (NASDAQ:BMGL) and Gaxos.ai (NASDAQ:GXAI) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, valuation, profitability, institutional ownership, media sentiment, analyst recommendations, risk and dividends.

In the previous week, Basel Medical Group had 1 more articles in the media than Gaxos.ai. MarketBeat recorded 1 mentions for Basel Medical Group and 0 mentions for Gaxos.ai. Basel Medical Group's average media sentiment score of 1.14 beat Gaxos.ai's score of 0.00 indicating that Basel Medical Group is being referred to more favorably in the media.

Company	Overall Sentiment
Basel Medical Group	Positive
Gaxos.ai	Neutral

Gaxos.ai has lower revenue, but higher earnings than Basel Medical Group.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Basel Medical Group	$8.90M	0.85	-$9.50M	N/A	N/A
Gaxos.ai	$1.93M	2.82	-$3.90M	-$0.50	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Basel Medical Group	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Gaxos.ai	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Basel Medical Group has a beta of 0.26, meaning that its share price is 74% less volatile than the broader market. Comparatively, Gaxos.ai has a beta of 0.96, meaning that its share price is 4% less volatile than the broader market.

42.6% of Gaxos.ai shares are held by institutional investors. 3.2% of Gaxos.ai shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Basel Medical Group has a net margin of 0.00% compared to Gaxos.ai's net margin of -64.81%. Basel Medical Group's return on equity of 0.00% beat Gaxos.ai's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Basel Medical Group	N/A	N/A	N/A
Gaxos.ai	-64.81%	-38.79%	-36.99%

Summary

Basel Medical Group beats Gaxos.ai on 6 of the 11 factors compared between the two stocks.

How does Basel Medical Group compare to NewGenIvf Group?

NewGenIvf Group (NASDAQ:NIVF) and Basel Medical Group (NASDAQ:BMGL) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, analyst recommendations, dividends, valuation, risk, profitability, institutional ownership and media sentiment.

In the previous week, NewGenIvf Group had 6 more articles in the media than Basel Medical Group. MarketBeat recorded 7 mentions for NewGenIvf Group and 1 mentions for Basel Medical Group. NewGenIvf Group's average media sentiment score of 1.65 beat Basel Medical Group's score of 1.14 indicating that NewGenIvf Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
NewGenIvf Group	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Basel Medical Group	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NewGenIvf Group	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Basel Medical Group	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

NewGenIvf Group has higher earnings, but lower revenue than Basel Medical Group.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NewGenIvf Group	$4.73M	0.48	$9.88M	N/A	N/A
Basel Medical Group	$8.90M	0.85	-$9.50M	N/A	N/A

66.2% of NewGenIvf Group shares are owned by institutional investors. 31.8% of NewGenIvf Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

NewGenIvf Group has a beta of -0.02, meaning that its stock price is 102% less volatile than the broader market. Comparatively, Basel Medical Group has a beta of 0.26, meaning that its stock price is 74% less volatile than the broader market.

Company	Net Margins	Return on Equity	Return on Assets
NewGenIvf Group	N/A	N/A	N/A
Basel Medical Group	N/A	N/A	N/A

Summary

NewGenIvf Group beats Basel Medical Group on 5 of the 8 factors compared between the two stocks.

How does Basel Medical Group compare to INVO Fertility?

Basel Medical Group (NASDAQ:BMGL) and INVO Fertility (NASDAQ:IVF) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, profitability, risk, media sentiment, valuation and earnings.

In the previous week, INVO Fertility had 1 more articles in the media than Basel Medical Group. MarketBeat recorded 2 mentions for INVO Fertility and 1 mentions for Basel Medical Group. Basel Medical Group's average media sentiment score of 1.14 beat INVO Fertility's score of 0.00 indicating that Basel Medical Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Basel Medical Group	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
INVO Fertility	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

12.0% of INVO Fertility shares are owned by institutional investors. 0.4% of INVO Fertility shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Basel Medical Group has a net margin of 0.00% compared to INVO Fertility's net margin of -116.29%. Basel Medical Group's return on equity of 0.00% beat INVO Fertility's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Basel Medical Group	N/A	N/A	N/A
INVO Fertility	-116.29%	-85.54%	-31.05%

INVO Fertility has a consensus price target of $20.00, suggesting a potential upside of 1,920.20%. Given INVO Fertility's stronger consensus rating and higher possible upside, analysts clearly believe INVO Fertility is more favorable than Basel Medical Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Basel Medical Group	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
INVO Fertility	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.50

Basel Medical Group has higher revenue and earnings than INVO Fertility.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Basel Medical Group	$8.90M	0.85	-$9.50M	N/A	N/A
INVO Fertility	$6.84M	0.36	-$25.13M	-$33.83	N/A

Basel Medical Group has a beta of 0.26, indicating that its share price is 74% less volatile than the broader market. Comparatively, INVO Fertility has a beta of 2.34, indicating that its share price is 134% more volatile than the broader market.

Summary

Basel Medical Group and INVO Fertility tied by winning 7 of the 14 factors compared between the two stocks.

Get Basel Medical Group News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BMGL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BMGL vs. The Competition

Export

Metric	Basel Medical Group	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$7.61M	$9.94B	$7.17B	$12.85B
Dividend Yield	N/A	2.56%	2.53%	8.56%
P/E Ratio	N/A	34.41	272.64	25.36
Price / Sales	0.85	4.87	617.63	97.95
Price / Cash	N/A	120.90	77.82	52.26
Price / Book	2.00	3.97	12.87	6.14
Net Income	-$9.50M	$310.54M	$3.47B	$349.06M
7 Day Performance	-6.97%	0.44%	0.36%	-0.33%
1 Month Performance	-14.62%	-0.22%	5.46%	0.57%
1 Year Performance	-78.95%	15.26%	24.95%	15.27%

Basel Medical Group Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
BMGL Basel Medical Group	0.9655 of 5 stars	$4.88 +2.0%	N/A	-79.8%	$7.61M	$8.90M	N/A	36	Gap Down
MGRX Mangoceuticals	0.4838 of 5 stars	$0.42 +9.4%	N/A	-82.3%	$9.10M	$460K	N/A	3	Positive News
AIDX 20/20 Biolabs	2.099 of 5 stars	$0.55 +7.8%	$5.00 +802.0%	N/A	$7.08M	$2.05M	N/A	14	High Trading Volume
GXAI Gaxos.ai	0.3178 of 5 stars	$0.88 +1.5%	N/A	-54.0%	$6.26M	$1.93M	N/A	3
NIVF NewGenIvf Group	2.4943 of 5 stars	$0.58 +4.5%	N/A	-99.9%	$3.44M	$4.73M	N/A	N/A	News Coverage Insider Trade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:BMGL) was last updated on 9/4/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Basel Medical Group (BMGL) Competitors

BMGL vs. MGRX, AIDX, GXAI, NIVF, and IVF

How does Basel Medical Group compare to Mangoceuticals?

Summary

How does Basel Medical Group compare to 20/20 Biolabs?

Summary

How does Basel Medical Group compare to Gaxos.ai?

Summary

How does Basel Medical Group compare to NewGenIvf Group?

Summary

How does Basel Medical Group compare to INVO Fertility?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BMGL vs. The Competition

Basel Medical Group Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Basel Medical Group (BMGL) Competitors

BMGL vs. MGRX, AIDX, GXAI, NIVF, and IVF

How does Basel Medical Group compare to Mangoceuticals?

Do analysts rate MGRX or BMGL?

Is MGRX or BMGL more profitable?

Do institutionals & insiders believe in MGRX or BMGL?

Does the media refer more to MGRX or BMGL?

Which has more volatility & risk, MGRX or BMGL?

Which has preferable earnings and valuation, MGRX or BMGL?

Summary

How does Basel Medical Group compare to 20/20 Biolabs?

Do analysts prefer BMGL or AIDX?

Is BMGL or AIDX more profitable?

Does the media refer more to BMGL or AIDX?

Which has stronger earnings and valuation, BMGL or AIDX?

Summary

How does Basel Medical Group compare to Gaxos.ai?

Does the media favor BMGL or GXAI?

Which has better earnings and valuation, BMGL or GXAI?

Do analysts prefer BMGL or GXAI?

Which has more risk and volatility, BMGL or GXAI?

Do institutionals & insiders have more ownership in BMGL or GXAI?

Is BMGL or GXAI more profitable?

Summary

How does Basel Medical Group compare to NewGenIvf Group?

Does the media favor NIVF or BMGL?

Do analysts prefer NIVF or BMGL?

Which has preferable valuation & earnings, NIVF or BMGL?

Do institutionals and insiders hold more shares of NIVF or BMGL?

Which has more risk & volatility, NIVF or BMGL?

Is NIVF or BMGL more profitable?

Summary

How does Basel Medical Group compare to INVO Fertility?

Does the media prefer BMGL or IVF?

Do insiders & institutionals hold more shares of BMGL or IVF?

Is BMGL or IVF more profitable?

Do analysts prefer BMGL or IVF?

Which has preferable valuation & earnings, BMGL or IVF?

Which has more risk & volatility, BMGL or IVF?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BMGL vs. The Competition

Basel Medical Group Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools